probenecid has been researched along with Deficiency, Glucosephosphatase in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adenwalla, HN | 1 |
| O'Connor, CR | 1 |
| Kawai, T | 1 |
| Homma, M | 1 |
| Kishi, H | 1 |
| Fujii, T | 1 |
| Koide, O | 1 |
2 other studies available for probenecid and Deficiency, Glucosephosphatase
| Article | Year |
|---|---|
Catastrophic axial gout causing paraplegia in a patient with glycogen storage disease.
Topics: Adult; Catastrophic Illness; Drug Therapy, Combination; Febuxostat; Glycogen Storage Disease Type I; | 2011 |
[A case report of von Gierke's disease with tophaceous gout].
Topics: Adult; Allopurinol; Glycogen Storage Disease Type I; Gout; Humans; Male; Pedigree; Probenecid | 1968 |